Lee Kyung-ha is the chairman of JW Group. He also serves as the CEO of the holding company, JW Holdings.
He is leading the development of innovative new drugs and business diversification.
He is the third-generation owner, as the grandson of Lee Ki-seok, the founder of JW Pharmaceutical.
He was born on August 29, 1963.
He graduated from the College of Pharmacy at Sungkyunkwan University and completed an MBA program at Drake University in the United States.
In 1986, he joined JW Pharmaceutical.
In 2001, he was appointed as the CEO and president of JW Pharmaceutical while concurrently serving as the CEO of key affiliates such as JW Medical.
In 2015, he became chairman and began full-scale management of the group.
While most pharmaceutical companies focused on generic and modified drugs, he dedicated himself to developing innovative new drugs.
He is known for his considerate leadership and places great importance on talent development.
#JWGroup #LeeKyungHa #PharmaceuticalIndustry #DrugInnovation #JWPharmaceutical #BusinessLeadership #CorporateStrategy #KoreanBusiness #HealthcareIndustry #TalentDevelopment